Sep 9 |
Top 2 Health Care Stocks That May Collapse This Quarter
|
Sep 9 |
Terns stock jumps as weight loss drug succeeds in early trial
|
Sep 9 |
Early study data puts Terns among obesity drug contenders
|
Sep 9 |
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
|
Sep 3 |
Terns Surges 29.6% in Three Months: Will the Momentum Continue?
|
Sep 1 |
Wall Street Breakfast: The Week Ahead
|
Aug 28 |
Wall Street Analysts Think Terns Pharmaceuticals (TERN) Could Surge 78.74%: Read This Before Placing a Bet
|
Aug 6 |
Terns Pharmaceuticals GAAP EPS of -$0.31
|
Aug 5 |
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
|
Aug 2 |
3 Biotech Stocks That Could Have Investors Grinning Soon
|